Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

OTHER 30NIH 8NETWORK 7INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Squamous Cell Carcinoma of Head and Neck 1

Interventions

pembrolizumab 152Carboplatin 116Cisplatin 70Paclitaxel 68Pemetrexed 65Gemcitabine 63Bevacizumab 59Docetaxel 48Fluorouracil 46Oxaliplatin 45Dexamethasone 44durvalumab 35Leucovorin 35Capecitabine 33Rituximab 32atezolizumab 30Lenalidomide 30Fulvestrant 30Injections 29Cyclophosphamide 29Prednisone 28Nivolumab 27Letrozole 26Cetuximab 26130-nm albumin-bound paclitaxel 26venetoclax 24pomalidomide 24enzalutamide 22Irinotecan 21daratumumab 20

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
INDUSTRY × Radiotherapy, Intensity-Modulated × 30 days × Clear all
NCT07219212 2026-05-08

LUMIRAY

Johnson & Johnson Enterprise Innovation Inc.

Phase 1 Recruiting
30 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck

Data powered by HemOnc (CC BY 4.0) Colophon âš¡